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A B S T R A C T   
Background: Community-based exercise rehabilitation programmes for chronic disease are an effective alterna-
tive to traditional hospital-based programmes. MedEx Wellness is a novel community-based exercise rehabili-
tation programme that integrates a range of chronic diseases. The aim of this trial was to investigate the effect of 
participating in MedEx Wellness on physical, clinical and psychological health. 
Methods: A prospective cohort study was conducted. Participants were recruited at induction to the MedEx 
Wellness programme following referral from healthcare professionals. Participants underwent a baseline 
assessment before commencing the exercise programme and repeat assessments at 3, 6 and 12 months. The 
primary outcome was cardiorespiratory fitness (6 minute- time trial) at 12 months. Secondary outcomes included 
health-related quality of life (EuroQoL-5D, Satisfaction with Life Scale, Warwick Edinburgh Mental Wellbeing 
Scale, Patient Health Questionnaire8, Functional Assessment of Cancer Therapy Questionnaire), free living ac-
tivity behavior (accelerometer) and healthcare utilization (recall questionnaire). Tertiary outcomes included 
blood pressure (24 h), biomarkers (lipids, glucose and C-reactive protein), other components of physical fitness, 
including strength (handgrip test, sit-to-stand test), flexibility (sit-and-reach test), body composition (body mass 
index and waist-to-hip ratio), and falls risk (timed up and go test), and claudication time (incremental treadmill 
walking test), cognitive function, including attention (Attention Network Task), memory (Luck & Vogel Visual 
Working Memory Task) and cognitive reserve. Exploratory outcomes included psychosocial determinants of 
physical activity (self-efficacy, social support, intentions). 
Discussion: This trial will evaluate whether participation in the MedEx Wellness programme has positive effects 
on physical, clinical and psychological health in individuals with a range of chronic diseases. 
Trial registration: ISRCTN Registry ISRCTN10351412.   
1. Introduction 
Noncommunicable diseases, also known as chronic diseases, account 
for greater than half of the overall global disease burden [1] which is 
predicted to continue to rise [2] potentially overwhelm the current 
healthcare systems. Identifying effective approaches to implementing 
evidence-based treatment strategies is crucial. There is substantial 
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evidence demonstrating for the beneficial effect of exercise in the sec-
ondary prevention of multiple chronic diseases [4,5]. Indeed, there are 
exceptionally few chronic diseases in which the burden of the disease, 
the comorbidities related to the disease, and the disease-related quality 
of life are not improved with exercise [4,5]. 
Exercise rehabilitation has traditionally been delivered in a hospital- 
based setting, primarily through cardiac or pulmonary rehabilitation 
programmes. Community-based programmes (CBP) are an effective 
alternative setting for the delivery of exercise-based rehabilitation [6,7]. 
CBP offer greater accessibility to patients and may help to address the 
poor participation rates in hospital-based exercise rehabilitation pro-
grammes [8]. 
Previous research involving CBP have focused primarily on single 
chronic disease populations [9–11] including cardiac [12], pulmonary 
[7,13], cancer [10,14], stroke [15], osteoarthritis [16], and peripheral 
arterial disease [17] cohorts. A systematic review of CBPs across chronic 
disease populations identified that the design and components of exer-
cise programmes were similar, irrespective of disease [18]. Considering 
the overlap in these programmes and the high prevalence of 
multi-morbidity [19], defined as the co-existence of two or more chronic 
conditions within an individual [20], an integrated approach to CBP for 
chronic disease management represents a more resource efficient 
strategy. 
MedEx Wellness (now rebranded as ExWell Medical) is a novel 
community-based exercise rehabilitation programme for individuals 
with chronic disease in Ireland. It offers group exercise classes with 
medical oversight for people with a range of chronic diseases, including 
cardiovascular disease (CVD), pulmonary disease, diabetes and cancer. 
The MedEx Wellness model provides a shared programme across chronic 
diseases and avoids duplication of programme infrastructure and con-
tent. The programme is a significant resource for healthcare pro-
fessionals and individuals living with chronic disease and hosts 
approximately 700 participant visits per week. The MedEx model is also 
unique in that it does not have a fixed duration and p articipants can 
attend the programme on a continuous or intermittent basis. They are 
however, encouraged to establish a lifelong relationship with MedEx 
Wellness. 
In this manuscript, we describe a cohort trial that investigated the 
effect of participating in the MedEx Wellness programme for 12 months 
on physical, clinical and psychological health in individuals living with 
chronic disease. 
2. Aims 
The aims of this trial were to evaluate the following hypotheses: 
2.1. Primary hypothesis 
Twelve months of participation in the MedEx Wellness programme 
will result in a significant improvement in physical health (cardiore-
spiratory fitness) assessed using the 6-min time trial in individuals with a 
range of established chronic diseases. 
2.2. Secondary hypotheses 
Twelve months of participation in the MedEx Wellness programme 
will result in a significant improvement in:  
a) Psychological health: assessed by EuroQoL-5D, Satisfaction with Life 
Scale, Warwick Edinburgh Mental Wellbeing Scale, the Patient 
Health Questionnaire 8 and the Functional Assessment of Cancer 
Therapy Questionnaire. 
b) Free Living Activity Behavior: physical activity and sedentary be-
haviors assessed by body-worn activity monitoring.  
c) Clinical health: healthcare utilization assessed by a recall 
questionnaire. 
2.3. Tertiary hypotheses 
Twelve months of participation in the MedEx Wellness programme 
will significantly improve:  
a) Clinical health: blood pressure assessed using a 24 h monitor and 
biomarkers including lipids, glucose and C-reactive protein.  
b) Physical health: strength assessed by handgrip test and sit-to-stand 
test; flexibility assessed by sit-and-reach test; body composition 
assessed by body mass index and waist-to-hip ratio; falls risk assessed 
by timed up and go test and claudication time assessed by an in-
cremental treadmill walking test.  
c) Psychological health: cognitive function, including attention 
assessed by Attention Network Task and working memory assessed 
by Luck & Vogel Visual Working Memory Task. 
2.4. Exploratory hypotheses 
Twelve months of participation in the MedEx Wellness programme 
will significantly improve psychosocial determinants of physical activity 
assessed by self-efficacy, social support and intentions. 
3. Methods 
3.1. Study design 
A prospective cohort study was conducted in participants recruited 
from patients referred to the MedEx Wellness programme by healthcare 
professionals, who were observed over the course of 12 months of 
participation in the programme. Outcomes were assessed at baseline and 
3, 6 and 12 months (Fig. 1). The trial was funded by the Health Service 
Executive (HSE) and approved by Dublin City University Ethics Com-
mittee (DCUREC: 2014/227). ISRCTN Registry ISRCTN10351412. This 
manuscript is reported using the PRISMA reporting guidelines. 
3.2. Study setting 
The trial was conducted at Dublin City University (DCU), Ireland. 
The MedEx Wellness programme operates as a partnership between 
members of academic staff from the School of Health and Human Per-
formance DCU and the Sports Services department in the institution on 
Abbreviations 
6 MTT 6 Minute Time Trial 
BMI Body Mass Index 
BP Blood Pressure 
CBP Community-Based Programme 
CVD Cardiovascular Disease 
DCU Dublin City University 
EQ-5D EuroQoL-5D-3L questionnaire 
HSE Health Service Executive 
NCD Non-Communicable Disease 
PHQ-8 Patient Health Questionnaire 8 
SAE Serious Adverse Event 
SWLS Satisfaction with Life Scale 
TUG Timed Get Up & Go Test 
WEMWS Warwick Edinburgh Mental Wellbeing Scale 
HDL-C High-Density Lipoprotein Cholesterol 
LDL-C Low-Density Lipoprotein Cholesterol 
CRP C-Reactive Protein  
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Eligibility criteria for inclusion were individuals aged >18 years with 
established non-communicable disease (NCD) referred to the MedEx 
Wellness programme by consultant physicians, phase III (outpatient) 
cardiac rehabilitation teams from three major tertiary hospitals and 
general practitioners in the local area. Exclusion criteria included un-
controlled cardiovascular disease (CVD), significant musculoskeletal or 
neurological conditions, cognitive decline and significant mental illness 
or intellectual disability that restricted participation in a physical 
training programme. 
3.3.1. Recruitment 
Participants were recruited at induction to the MedEx Wellness 
programme. Programme inductions took place weekly and involved 
10–20 individuals per week. Potential participants were provided with a 
full oral explanation and a plain language statement detailing the trial. 
Participants provided written informed consent at this visit. 
3.4. MedEx Wellness community-based exercise programme 
The exercise intervention was delivered as part of the MedEx Well-
ness programme, which is outlined in Fig. 2. Participants underwent an 
induction to the programme, which involved 3 visits that provided: i) 
information on the programme purpose, structure and logistics; ii) a 
group exercise consultation and iii) a beginner exercise class. The ex-
ercise consultation was delivered by researchers trained in exercise 
consultation delivery and adhered to a motivational interviewing style. 
The aim of the consultation was to use behaviour change techniques to 
improve exercise adherence. The consultations focused on the benefits 
and barriers to exercise, problem solving, goal setting and action plan-
ning. The exercise consultations were repeated at 1, 3 and 6 months and 
involved a review of behaviour goals and feedback on progress. The 
Fig. 1. Trial algorithm.  
Fig. 2. The MedEx Wellness Programme  
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beginner class followed a similar format as regular MedEx Wellness 
classes but involved a smaller group size (approx. 10–15 participants). 
The beginner classes introduced the participants to the exercise equip-
ment and demonstrated proper techniques with the aim to improve self- 
efficacy and foster social support to improve programme initiation and 
adherence. 
Following induction, participants were advised to attend 2 MedEx 
Wellness supervised group exercise classes per week. The number of 
participants at the exercise classes ranged from 30 to 75 (dependent on 
day of the week) and classes were supervised at a ratio of one instructor 
to 15 participants. MedEx Wellness staff are certified in Cardiac Pre-
vention and Rehabilitation and the programme has medical oversight 
from the MedEx Wellness Chief Medical Officer (physician). The cost of 
participation was €7/8 (with/without a medical card) per session or 
€45/50 (with/without a medical card) per month (parking was included 
in this payment). The MedEx Wellness exercise intervention is described 
subsequently using the FITT (frequency, intensity, time, type) principle. 
3.4.1. Frequency 
Participants were advised to attend �2 supervised group exercise 
classes per week and encouraged to attend the same classes every week 
in order to foster social-support and habit formation. 
3.4.2. Intensity 
For the aerobic component of the exercise classes, participants were 
instructed to work at an intensity at which they “feel moderately 
breathless, have a red face and sweat”. For the resistance component of 
the exercise classes, participants aimed to achieve 15–20 repetitions at 
resistance that felt “tough” at each station. 
3.4.3. Time 
The class included a 15 min warm-up followed by a 40 min exercise 
training phase and a 5 min cool-down. For the exercise training phase, 
depending on the class size, participants were split into two or three 
groups: if �30 participants were present, the class was divided into two 
groups that alternated between 20 min of aerobic exercise and 20 min 
resistance exercise; and if >30 participants were present, the class was 
divided into three groups that rotated between 10 min of aerobic exer-
cise, 10 min of resistance exercise and 10 min of a combined aerobic and 
resistance circuit. For the resistance component, participants performed 
exercises at each resistance station for 60 s aiming to achieve 15–20 
repetitions. 
3.4.4. Type 
The aerobic component of the exercise classes involved the use of 
different equipment based on participant preference and ability, 
including treadmills, cycle ergometers, rowers and elliptical ergometers. 
Resistance training involved a circuit of 10–15 stations that included 
upper and lower body exercises using body weight resistance, weight 
machines and hand-weights. The combined aerobic and resistance cir-
cuit was led by an instructor and involved a combination of free aerobic 
exercises and calisthenics, for example, jumping jacks, toe taps, squats 
and wall press. 
Following completion of the class, participants engaged in a social 
tea or coffee. Adherence to the programme was monitored as the 
number of sessions attended, which was electronically recorded by 
swipe access to the facility. 
3.5. Outcome measures 
Participants underwent a series of outcome assessments at baseline 
and 3, 6 and 12 months. Outcome measurements are presented in 
Table 1. The assessments were conducted over 2 visits (and 3 visits for 
individuals with intermittent claudication). Fig. 3 provides an overview 
of the study flow algorithm. Visit 1 and 2 were separated by 6 days 
whilst visit 2 and 3 by 24 h. Visit 1 involved a fasting blood sample, 
questionnaire completion to obtain demographic information and the 
psychosocial determinants of physical activity, and assessment of body 
composition, strength and flexibility. Participants were provided with a 
take home questionnaire that assessed health-related quality of life and 
were provided with an activPAL3 micro activity monitor (PAL Tech-
nologies Ltd. Glasgow, Scotland) to wear for 6 days. Visit 2 involved 
assessments of cognitive function, cardiorespiratory fitness and falls 
risk. Participants were provided with an ambulatory blood pressure (BP) 
monitor to wear for 24 h and a take home questionnaire that assessed 
cognitive reserve. Participants were encouraged to complete question-
naires independently but where required, a member of the research 
team or a family member or friend provided assistance. Participants 
with intermittent claudication performed a treadmill test at visit 3, 
which was organized prior to a scheduled exercise class. 
3.6. Primary outcome 
Physical health: cardiorespiratory fitness assessed using the 6-min 
time trial (6MTT) [21,22]. Participants were instructed to cover as 
much distance as possible in 6 min while walking, running or a com-
bination, back and forth on a flat indoor 20 m course. Participants 
received a standard set of instructions adapted from the ATS guidelines 
for the 6-min walk test [23]. No warm-up was permitted. The position on 
the 20 m course at which the participant stopped at the end of the 6 min 
was marked with a cone and the distance covered in the final partial lap 
was measured to the nearest metre using a measuring tape. The total 
distance covered was recorded. 
Table 1 
Outline of outcome measurement assessment time points.  









Physical health: 6MTT x x x x 
Secondary outcomes: 
Psychological health     
EQ-5D-3L x x x x 
PHQ-8 x x x x 
SWLS x x x x 
WEMWBS x x x x 
FACT x x x x 
Physical health: Free living 
activity behaviour 
x x x x 
Clinical health: Healthcare 
utilization 
x   x 
Tertiary outcomes: 
Clinical health: Biomarkers 
Blood pressure x x x x 
Lipids x x x x 
Glucose x x x x 
CRP x x x x 
Physical health 
Body composition x x x x 
Strength x x x x 
Flexibility x x x x 
Falls risk x x x x 
Claudication time x x x x 
Psychological health: Cognitive function 
Attentionand visual working 
memory 
x x x x 
Cognitive reserve x    
Exploratory outcomes: 
Psychological health: Psychosocial determinants of physical activity 
Self-efficacy x x x x 
Social support for exercise x x x x 
Intentions for exercise x x x x 
Abbreviations: 6 MTT - 6 Minute Time Trial; EQ-5D - EuroQoL-5D-3L ques-
tionnaire; PHQ-8 - The Patient Health Questionnaire; SWLW - TheSatisfaction 
with Life Scale; WEMWS - Warwick Edinburgh Mental Wellbeing Scale; FACT - 
Functional Assessment of Cancer Therapy; CRP - C-Reactive Protein (CRP). 
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3.7. Secondary outcomes 
Psychological health assessed by the following questionnaires:  
� The EuroQoL-5D-3L (EQ-5D), which consists of two components: 
health state description and health evaluation. The description 
component is comprised of five dimensions: mobility, self-care, usual 
activities, pain/discomfort and anxiety/depression. Each dimension 
has 3 levels: no problems, some problems and extreme problems. The 
evaluation component records the patient’s self-rated health on a 
vertical visual analogue scale where the endpoints are labelled ‘best 
imaginable health state’ and ‘worst imaginable health state’ [24,25].  
� The Satisfaction with Life Scale (SWLS), a 5-item scale designed to 
measure global cognitive judgment of subjective wellbeing [26].  
� The Warwick Edinburgh Mental Wellbeing Scale (WEMWS), a 14- 
item positively worded scale covering both feeling and functional 
aspects of mental wellbeing [27].  
� The Patient Health Questionnaire (PHQ-8), an 8-item validated and 
widely used diagnostic and severity measure for depression [28].  
� The Functional Assessment of Cancer Therapy (FACT) questionnaire 
was completed by participants with cancer only. This is a 40-item 
Fig. 3. Outline of data collection.  
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questionnaire that includes five domains: physical, social/family, 
emotional, function and cancer-specific, to evaluate quality of life 
and fatigue in patients with cancer [29]. It is composed of a general 
component (FACT-G) and cancer specific subscales. 
Free living activity behavior assessed using: 
The activPAL3 micro accelerometer, a device that measures bodily 
accelerations using a triaxial accelerometer, sampling at 20 Hz. The 
device was worn on the midpoint of the anterior aspect of the thigh. It 
was covered with a water-resistant nitrile sleeve and attached to the skin 
using a Tegaderm film adhesive dressing. Participants were instructed to 
wear the device continuously for 6 consecutive days, except during 
water immersion activities (i.e. swimming and bathing). 
Raw acceleration data were processed and stored in a range of file 
formats, including csv files or 15 s epoch summary files. Proprietary 
algorithms classify activities into sitting/lying time, standing time, 
stepping time, step count and activity counts. Only datasets that provide 
�4 valid days of activity data, including 1 weekend day, will be pro-
cessed for analysis. A valid day will be defined as �600 min of recording 
during daytime hours (i.e. 7 a.m. to 11 p.m.) [18]. Non-wear time will be 
defined as �60 min of consecutive zero accelerometer counts [19]. 
Sedentary behavior characteristics will be examined using a customized 
MATLAB® (version 7.0.1, The Mathworks Inc, Natick, MA, USA) soft-
ware programme [19]. The programme has been previously described 
[19]. Briefly, the number and duration of sedentary bouts per day will be 
calculated. Sedentary bouts will be categorized by specific durations, 
namely <5 min, 5–10 min, 11–20 min, 21–30 min, 31–40 min, 41–60 
min, >60 min, >90 min. The number of sedentary bouts and the total 
duration spent in sedentary bouts in each category will be calculated. 
Clinical health assessed by: 
An 8-item healthcare utilization questionnaire developed based on 
The Irish Longitudinal Study on Ageing (TILDA) [30,31]. The ques-
tionnaire captured self-reported 12-month recall of health service use. 
Participants were asked about: i) medical card cover; ii) GP visits; iii) 
hospital emergency service visits; iv) outpatient hospital visits; v) 
whether an outpatient hospital visit was a public/private visit; vi) nights 
spent in hospital; vii) whether nights spent in hospital were a pub-
lic/private visit; viii) days taken off work due to illness. 
3.8. Tertiary outcomes 
Clinical health assessed by:  
� An ambulatory BP monitor (Oscar 2, SunTech Medical, Inc, NC USA), 
issued to participants to wear for 24 h. Data was retrieved from the 
device using the AccWin Pro 3 PC (SunTech Medical, Inc, NC USA). 
Average systolic and diastolic daytime, night-time and 24-h blood 
pressures were derived.  
� Venous blood samples were taken following an overnight fast. Serum 
vacutainers were left to stand for 30 min before centrifugation at 
3000 rpm (1600 g) for 15 min at 4 �C. Serum triglycerides, total 
cholesterol, high-density lipoprotein cholesterol (HDL-C), low- 
density lipoprotein cholesterol (LDL-C), fasting glucose and C-reac-
tive protein (CRP) were determined using spectrophotometric as-
says, performed on an automated bench-top clinical chemistry 
system (ACE®, Alfa Wassermann B.V., Netherlands) using the 
appropriate reagents, calibrators and controls (Randox Laboratories, 
UK). 
Physical health assessed by:  
� Body composition: Height and body mass were measured using a 
stadiometer and electronic scale (model 707 balance scales: Seca 
GmbH, Hamburg, Germany), respectively. Body mass index (BMI) 
was calculated as body mass in kilograms divided by squared height 
in metres. Waist and hip circumferences were measured by a trained 
researcher using a tape measure and waist to hip ratio was derived.  
� Muscle strength: Lower body strength was assessed using the 10 
repetition sit to stand test [32], which records the time taken to stand 
and sit 10 times as fast as possible. The best of two attempts was 
recorded. Handgrip strength was measured in the dominant arm 
using a hand-held dynamometer (Takei 5401 Handgrip Digital 
Dynamometer). The average of three attempts was recorded.  
� Flexibility: assessed using a modified sit and reach test [33], whereby 
a sit and reach box (Eveque Leisure Equipment Ltd, Cheshire, UK) 
was placed on a bench. While sitting on the bench,participants were 
instructed to extend their legs fully with feet flat against the box and 
were asked to flex forward to reach their fingertips as far as possible 
along the measurement scale. The best of three attempts was 
recorded.  
� Falls risk: A 3-item questionnaire was used to identify participants 
who reported falling one or more times in the previous year or re-
ported a fear of falling or problems with balance or walking. A Timed 
Get Up and Go (TUG) Test [34] assessed the time taken to rise from a 
chair of standardized height, walk a fixed distance of 3m, turn, return 
to the chair, and sit down again. The bestof two attempts was 
recorded.  
� Claudication time: An incremental treadmill walking test using the 
Gardner protocol [35] of 3.2 km.h-1 and 0% grade, with a subsequent 
2% increase in grade every 2 min was used to determine time to the 
onset of and absolute claudication pain in participants with symp-
toms of intermittent claudication resulting from peripheral arterial 
disease. 
Psychological health assessed by:  
� Attention control: assessed using the Attention Network Task [36]. 
The computerised task measured three functionally and independent 
aspects of attention control crucial to everyday cognitive functioning 
by recording performance accuracy and average reaction time to a 
correctly detected target amongst flankers (i.e. a set of response in-
hibition tests used to assess the ability to suppress responses that are 
inappropriate in a particular context): (1) alertness, (2) attentional 
orienting, and (3) executive function.  
� Visual working memory: measured using the Luck & Vogel Visual 
Working Memory Task [37]. The computerised task measures per-
formance accuracy and average reaction times to correct detection of 
a change in a visual array of objects. The set size of the object array 
varies from small to large. 
Both computerised tasks are used with open permissions from the 
Psychology Experiment Building Language (PEBL) site: http://peblblog. 
blogspot.ie/2014/07/overview-of-some-of-new-tests-in-pebl.html. 
Benchmark tests have been reported within various populations to 
establish timing precision [38].  
� Cognitive reserve: assessed at baseline only using the Cognitive 
Reserve Questionnaire, http://www.cognitivereserveindex.org/ 
[39]. The questionnaire measures demographics, education, and 
working activity including physical, social and intellectually chal-
lenging activity. 
3.9. Exploratory outcomes 
Selected psychosocial determinants of physical activity were 
assessed. Barrier self-efficacy and self-regulatory self-efficacy for phys-
ical activity were assessed using an established 13-item scale [40] and a 
modified 11-item scale [41,42], respectively. Social support from family 
and friends for physical activity was assessed using a validated 10-item 
tool [43]. A modified 6-item measure was used to assess intentions for 
exercise [44]. 
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3.10. Safety 
Any adverse event was recorded and reported to the MedEx Wellness 
Chief Medical Officer and the principal investigator. Serious adverse 
events (SAE) were defined as all-cause mortality or hospitalization for 
cardiovascular complications. Other adverse events included training- 
related adverse events such as musculoskeletal problems that pre-
vented exercise participation or other adverse events that interrupted 
the exercise intervention. Follow-up telephone calls to schedule repeat 
assessments provided an opportunity for participants to report adverse 
events. There was also an opportunity during the exercise classes for 
participants to report adverse events to the exercise instructors or the 
programme’s Chief Medical Officer, which were then communicated to 
the research team. 
3.11. Data analysis 
3.11.1. Sample size 
The critical determination of the sample size was the standard de-
viation of the change in 6MTT distance from baseline to 12 months. The 
standard deviation estimate used was 90 m [45]. The minimum differ-
ence to be detected was 25 m [46]. For a power of 80% and two-sided 
significance of 5%, a sample size of 104 participants was required. To 
account for drop out, 400 was the target sample size. 
3.11.2. Procedures for data checking and entering 
Primary and secondary outcome data for physical health and psy-
chological health (except cognitive assessments) outcomes will be 
handled using double data entry and cleaning. Due to lack of resources, 
all other outcome measures will be handled using single data entry. 
3.11.3. Statistical analyses 
Analyses will be performed using IBM SPSS Statistics 24. Continuous 
variables will be reported as mean (range), mean (standard deviation) or 
median (inter-quartile range), depending on distribution, and categori-
cal variables as frequency (%). Baseline demographics and number of 
chronic diseases (including type) will be reported descriptively. Prior to 
statistical analysis, the Shapiro-Wilks test will be applied to check for 
normality. To investigate longitudinal changes in repeated measures 
variables, linear mixed model analysis (MMA) will be used. A MMA is an 
appropriate approach to modelling time series data that contains 
repeated measures for numerous subjects [47]. It does not require 
complete data sets and it will not exclude participants missing a repeat 
assessment timepoint [48]. Bonferroni post-hoc stratified analysis 
comparing estimated marginal means at each timepoint will be per-
formed for variables that indicate a significant main effect for time. 
4. Discussion 
Exercise is an evidence-based secondary prevention strategy for 
chronic disease. It is associated with reductions in recurrent events, 
future complications, hospital readmissions and mortality in several 
chronic diseases [4,49]. Exercise can also restore health, including 
improving physical function, functional independence and 
health-related quality of life [3,5]. Despite the established benefits, 
referral, uptake and adherence rates to exercise rehabilitation pro-
grammes in the hospital setting are suboptimal, with less than 35% of 
eligible patients participating in cardiac rehabilitation [12,50]. 
Commonly cited barriers to participation in exercise rehabilitation 
programmes include environmental factors, such as distance to the fa-
cility, lack of transport and health system resources [51,52]. A quanti-
tative review of 32 cardiac rehabilitation studies found that patients 
were more likely to participate when the programmes were easily 
accessible [34]. Embedding exercise rehabilitation services within the 
community may improve uptake and compliance, as well as shift the 
resource burden from the healthcare system. 
CBPs are effective models of exercise rehabilitation, with some 
research reporting similar benefits compared to hospital-based pro-
grammes [6,7]. They have been associated with improvements in 
physical function and health-related quality of life in a variety of clinical 
populations, including cardiac [12], pulmonary [7,13], cancer [10,14], 
stroke [15], osteoarthritis [16], and peripheral arterial disease [17]. 
These previous studies have focused on the effect of CBPs on a single 
chronic disease. However, multi-morbidity, commonly defined as the 
co-existence of two or more chronic conditions within an individual 
[20], is a growing challenge for healthcare systems and is associated 
with the ageing population [19]. The increasing levels of 
mutli-morbidity threaten the sustainability of current healthcare ap-
proaches and necessitate fundamental change to the current model [53]. 
In relation to exercise rehabilitation, a common chronic disease model is 
warranted. 
A systematic review of the structure and delivery of CBPs across 
chronic disease populations identified that the design and components 
of programmes were similar, irrespective of chronic disease [18]. Spe-
cifically, the primary components of >85% of the programmes included 
a combination of aerobic and resistance exercise. The frequency of ex-
ercise sessions was typically 2–3 days per week and sessions were 
generally 40–60 min in duration. These findings highlight that it is un-
necessary to have separate programmes for single chronic conditions 
and that such programmes can be easily applied across a range of con-
ditions with minimal disease-specific adjustments. An integrated model 
is likely to represent a more resource efficient approach. 
The novelty of the MedEx Wellness model is that it integrates a range 
of chronic diseases with a shared common infrastructure and content, 
including facilities, staffing, operating procedures and standards, pa-
tient information handling, exercise prescription and programme con-
tent, and the programme is financially self-sufficient; its business model 
has been described in the National Exercise Referral Framework [54]. It 
is also unique in terms of programme duration; it is not a fixed duration, 
participants can attend the programme on a continuous or intermittent 
basis. Other CBP range from 8 weeks to 18 months in duration [15]. The 
MedEx Wellness approach supports the long-term maintenance of 
physical activity and exercise. All of these features combine to make the 
MedEx Wellness model scalable and sustainable and it represents a po-
tential public health model for chronic disease rehabilitation. 
4.1. Study limitations 
The primary limitation of this study is the lack of a usual care 
comparison group. As the study setting was within an established pro-
gramme in the community, withholding service to allow for a controlled 
trial was not considered ethically appropriate. Maturation may threaten 
the study validity given the population included, as changes in health 
status may have occurred over the 12-month period. Selection bias is 
present as participants were recruited from those who attended induc-
tion to the community-based exercise rehabilitation programme and no 
data was collected on those that were not referred or declined to attend. 
Additionally, study uptake rates (screening logs) were not recorded. 
Study limitations also include that the assessor was not blinded to 
outcome measures. 
5. Conclusion 
This trial investigated the clinical effectiveness of the MedEx Well-
ness programme. The extent of the trial outcome measures will provide a 
holistic view of the physical, clinical and psychological effect of the 
programme. 
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